FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC
Company: THERAPEUTICSMD INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS | 
|---|---|---|---|---|---|---|---|
| IMVEXXY | ESTRADIOL | 0.004MG | INSERT;VAGINAL | Prescription | None | Yes | No | 
| IMVEXXY | ESTRADIOL | 0.01MG | INSERT;VAGINAL | Prescription | None | Yes | Yes | 
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url | 
|---|---|---|---|---|---|---|---|
| 05/29/2018 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD | 
    
     
        
        	Label (PDF)
         Letter (PDF) Review  | 
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208564s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208564Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/208564Orig1s000TOC.cfm | 
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url | 
|---|---|---|---|---|---|
| 11/21/2019 | SUPPL-3 | Labeling-Package Insert | 
	
                                         
	
	
	Label (PDF)
	
	 Letter (PDF)  | 
	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208564s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208564Orig1s003ltr.pdf | |
| 11/16/2021 | SUPPL-2 | Labeling-Package Insert | 
		
		
        
		 Label is not available on this site.  | 
	
	
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert  | 
	Note | Url | 
|---|---|---|---|---|---|
| 11/21/2019 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208564s003lbl.pdf | |
| 05/29/2018 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208564s000lbl.pdf |